Current status on anti-infective treatment of acute pancreatitis

doi:10.16139/j.1007-9610.2022.06.017

Abstract

Abstract:

Acute pancreatitis (AP) is a common cause of emergent patients and common severe disorders of hospital admission. This review includes the characteristic of inflammatory reaction from AP, the pattern and the aetiology of AP with infection, the necessity of preventive use of antibacterials, antimicrobial treatment of AP with infection, use of antibacterials for extra-pancreatic infections, surgical intervention of anti-infective treatment. Related recognition and clinical experience in treatment of AP were provided. Extra-pancreatic infections appeared in the patients with AP indicating the increase in disease severity. Compared to the patients with aseptic necrosis, the patients with extra-pancreatic infections might have organ failure, increasing in rescue risk for into intensive care unit, and with mortality increasing. Early diagnosis, infection control and proper treatment with antibacterials will be the footing and base for the treatment of AP combined infection.

Key words: Acute pancreatitis, Antibacterials, Pancreatic infection

CLC Number:

WEN Yi, NI Tongtian, CHEN Ying, MAO Enqiang. Current status on anti-infective treatment of acute pancreatitis[J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 563-568.

References 53

[1]	Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis[J]. Lancet, 2020, 396(10252):726-734. doi: S0140-6736(20)31310-6 pmid: 32891214
[2]	Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis[J]. Nat Rev Gastroenterol He-patol, 2019, 16(3):175-184.
[3]	Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review[J]. JAMA, 2021, 325(4):382-390. doi: 10.1001/jama.2020.20317 pmid: 33496779
[4]	Olesen SS, Harakow A, Krogh K, et al. Hypertrigly-ceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study[J]. Pancreatology, 2021, 21(2):334-341. doi: 10.1016/j.pan.2021.02.005 pmid: 33608229
[5]	Pascual I, Sanahuja A, García N, et al. Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis: cohort analysis of 1457 patients[J]. Pancreatology, 2019, 19(5):623-629. doi: S1424-3903(19)30607-6 pmid: 31229460
[6]	Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62(1):102-111. doi: 10.1136/gutjnl-2012-302779 URL
[7]	Párniczky A, Lantos T, Tóth EM, et al. Antibiotic therapy in acute pancreatitis: from global overuse to evidence based recommendations[J]. Pancreatology, 2019, 19(4):488-499. doi: S1424-3903(19)30091-2 pmid: 31068256
[8]	Uhl W, Warshaw A, Imrie C, et al. IAP guidelines for the surgical management of acute pancreatitis[J]. Pancrea-tology, 2002, 2(6):565-573.
[9]	Lévy P, Boruchowicz A, Hastier P, et al. Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients[J]. Pancreatology, 2005, 5(4-5):450-456. doi: 10.1159/000086547 pmid: 15985771
[10]	Wang YL, Hu R, Lugea A, et al. Ethanol feeding alters death signaling in the pancreas[J]. Pancreas, 2006, 32(4):351-359. doi: 10.1097/01.mpa.0000220859.93496.e1 URL
[11]	Marstrand-Joergensen MR, Bertilsson S, Kalaitzakis E. Extrapancreatic infections are common in acute pancreatitis and they are related to organ failure: a population-based study[J]. Eur J Gastroenterol Hepatol, 2020, 32(10):1293-1300. doi: 10.1097/MEG.0000000000001847 URL
[12]	Elder AS, Saccone GT, Dixon DL. Lung injury in acute pancreatitis: mechanisms underlying augmented se-condary injury[J]. Pancreatology, 2012, 12(1):49-56. doi: 10.1016/j.pan.2011.12.012 URL
[13]	Phillip V, Steiner JM, Algül H. Early phase of acute pancreatitis: assessment and management[J]. World J Gastrointest Pathophysiol, 2014, 5(3):158-168. doi: 10.4291/wjgp.v5.i3.158 pmid: 25133018
[14]	Baltatzis M, Mason JM, Chandrabalan V, et al. Antibiotic use in acute pancreatitis: an audit of current practice in a tertiary centre[J]. Pancreatology, 2016, 16(6):946-951. doi: S1424-3903(16)31180-2 pmid: 27613614
[15]	Jiang X, Shi JY, Wang XY, et al. The impacts of infectious complications on outcomes in acute pancreatitis: a retrospective study[J]. Mil Med Res, 2020, 7(1):38. doi: 10.1186/s40779-020-00265-5 pmid: 32799919
[16]	Liu J, Huang L, Luo M, et al. Bacterial translocation in acute pancreatitis[J]. Crit Rev Microbiol, 2019, 45(5-6):539-547. doi: 10.1080/1040841X.2019.1621795 pmid: 31851854
[17]	Jain S, Mahapatra SJ, Gupta S, et al. Infected pancreatic necrosis due to multidrug-resistant organisms and persistent organ failure predict mortality in acute pancreatitis[J]. Clin Transl Gastroenterol, 2018, 9(10):190.
[18]	Mowbray NG, Ben-Ismaeil B, Hammoda M, et al. The microbiology of infected pancreatic necrosis[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(5):456-460. doi: 10.1016/j.hbpd.2018.08.007 URL
[19]	Moka P, Goswami P, Kapil A, et al. Impact of antibiotic-resistant bacterial and fungal infections in outcome of acute pancreatitis[J]. Pancreas, 2018, 47(4):489-494. doi: 10.1097/MPA.0000000000001019 URL
[20]	Schwender BJ, Gordon SR, Gardner TB. Risk factors for the development of intra-abdominal fungal infections in acute pancreatitis[J]. Pancreas, 2015, 44(5):805-807. doi: 10.1097/MPA.0000000000000334 URL
[21]	Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis[J]. World J Emerg Surg, 2019, 14:27. doi: 10.1186/s13017-019-0247-0 pmid: 31210778
[22]	Pando E, Alberti P, Hidalgo J, et al. The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis[J]. Pancreatology, 2018, 18(5):486-493. doi: 10.1016/j.pan.2018.05.481 URL
[23]	Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin(PCT): a prospective international multicenter study[J]. Ann Surg, 2007, 245(5):745-754. doi: 10.1097/01.sla.0000252443.22360.46 URL
[24]	Siriwardena AK, Jegatheeswaran S, Mason JM, et al. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis(PROCAP): study protocol for a randomised controlled trial[J]. Trials, 2019, 20(1):463. doi: 10.1186/s13063-019-3549-3 pmid: 31358032
[25]	Stirling AD, Moran NR, Kelly ME, et al. The predictive value of C-reactive protein (CRP) in acute pancreatitis—is interval change in CRP an additional indicator of severity?[J]. HPB (Oxford), 2017, 19(10):874-880. doi: 10.1016/j.hpb.2017.06.001 URL
[26]	Zhong Y, Yu Z, Wang L, et al. Combined detection of procalcitonin, heparin-binding protein, and interleukin-6 is a promising assay to diagnose and predict acute pancreatitis[J]. J Clin Lab Anal, 2021, 35(8):e23869.
[27]	Kandil M, Khalil G, El-Attar E, et al. Accuracy of heparin binding protein: as a new marker in prediction of acute bacterial meningitis[J]. Braz J Microbiol, 2018, 49 Suppl 1:213-219. doi: S1517-8382(17)31023-7 pmid: 30166267
[28]	Tian F, Li H, Wang L, et al. The diagnostic value of serum C-reactive protein, procalcitonin, interleukin-6 and lactate dehydrogenase in patients with severe acute pancreatitis[J]. Clin Chim Acta, 2020, 510:665-670. doi: 10.1016/j.cca.2020.08.029 pmid: 32828732
[29]	van Grinsven J, van Brunschot S, van Baal MC, et al. Natural history of gas configurations and encapsulation in necrotic collections during necrotizing pancreatitis[J]. J Gastrointest Surg, 2018, 22(9):1557-1564. doi: 10.1007/s11605-018-3792-z pmid: 29752684
[30]	Schuts EC, Hulscher MEJL, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis[J]. Lancet, Infect Dis, 2016, 16(7):847-856. doi: S1473-3099(16)00065-7 pmid: 26947617
[31]	Baltatzis M, Jegatheeswaran S, O′Reilly DA, et al. Antibiotic use in acute pancreatitis: global overview of compliance with international guidelines[J]. Pancreatology, 2016, 16(2):189-193. doi: 10.1016/j.pan.2015.12.179 pmid: 26804006
[32]	Moggia E, Koti R, Belgaumkar AP, et al. Pharmacological interventions for acute pancreatitis[J]. Cochrane Database Syst Rev, 2017, 4:CD011384.
[33]	Ukai T, Shikata S, Inoue M, et al. Early prophylactic antibiotics administration for acute necrotizing pancreatitis: a meta-analysis of randomized controlled trials[J]. J He-patobiliary Pancreat Sci, 2015, 22(4):316-321.
[34]	Poropat G, Radovan A, Peric M, et al. Prevention of infectious complications in acute pancreatitis: results of a single-center, randomized, controlled trial[J]. Pancreas, 2019, 48(8):1056-1060. doi: 10.1097/MPA.0000000000001368 URL
[35]	Baron TH, DiMaio CJ, Wang AY, et al. American Gastroenterological Association Clinical Practice Update: management of pancreatic necrosis[J]. Gastroenterology, 2020, 158(1):67-75. doi: S0016-5085(19)41293-6 pmid: 31479658
[36]	Schepers NJ, Bakker OJ, Besselink MG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis[J]. Gut, 2019, 68(6):1044-1051. doi: 10.1136/gutjnl-2017-314657 pmid: 29950344
[37]	Werge M, Novovic S, Schmidt PN, et al. Infection increases mortality in necrotizing pancreatitis: a systematic review and meta-analysis[J]. Pancreatology, 2016, 16(5):698-707. doi: 10.1016/j.pan.2016.07.004 pmid: 27449605
[38]	Hines OJ, Pandol SJ. Management of severe acute pancreatitis[J]. BMJ, 2019, 367:l6227.
[39]	Isayama H, Nakai Y, Rerknimitr R, et al. Asian consensus statements on endoscopic management of walled-off necrosis part 1: epidemiology, diagnosis, and treatment[J]. J Gastroenterol Hepatol, 2016, 31(9):1546-1554. doi: 10.1111/jgh.13394 URL
[40]	Greenberg JA, Hsu J, Bawazeer M, et al. Clinical practice guideline: management of acute pancreatitis[J]. Can J Surg, 2016, 59(2):128-140. pmid: 27007094
[41]	Otto W, Komorzycki K, Krawczyk M. Efficacy of anti-biotic penetration into pancreatic necrosis[J]. HPB (Oxford), 2006, 8(1):43-48. doi: 10.1080/13651820500467275 pmid: 18333238
[42]	Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China[J]. Clin Infect Dis, 2018, 67(suppl 2):S128-S134. doi: 10.1093/cid/ciy657 URL
[43]	Reuken PA, Albig H, Rödel J, et al. Fungal infections in patients with infected pancreatic necrosis and pseudocysts: risk factors and outcome[J]. Pancreas, 2018, 47(1):92-98. doi: 10.1097/MPA.0000000000000965 URL
[44]	Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 62(4):e1-e50. doi: 10.1093/cid/civ933 URL
[45]	Wolbrink DRJ, Kolwijck E, Ten Oever J, et al. Management of infected pancreatic necrosis in the intensive care unit: a narrative review[J]. Clin Microbiol Infect, 2020, 26(1):18-25. doi: 10.1016/j.cmi.2019.06.017 URL
[46]	Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review[J]. JAMA, 2019, 322(24):2422-2434. doi: 10.1001/jama.2019.19411 pmid: 31860051
[47]	Barrie J, Jamdar S, Smith N, et al. Mis-use of antibiotics in acute pancreatitis: insights from the United Kingdom′s National Confidential Enquiry into patient outcome and death (NCEPOD) survey of acute pancreatitis[J]. Panc-reatology, 2018, 18(7):721-726.
[48]	Lu JD, Cao F, Ding YX, et al. Timing, distribution, and microbiology of infectious complications after necrotizing pancreatitis[J]. World J Gastroenterol, 2019, 25(34):5162-5173. doi: 10.3748/wjg.v25.i34.5162 URL
[49]	Al-Omran M, Albalawi ZH, Tashkandi MF, et al. Enteral versus parenteral nutrition for acute pancreatitis[J]. Cochrane Database Syst Rev, 2010(1):CD002837.
[50]	Nesvaderani M, Eslick GD, Faraj S, et al. Study of the early management of acute pancreatitis[J]. ANZ J Surg, 2017, 87(10):805-809. doi: 10.1111/ans.13330 pmid: 26403670
[51]	Luckhurst CM, Hechi ME, Elsharkawy AE, et al. Improved mortality in necrotizing pancreatitis with a multidisciplinary minimally invasive step-up approach: comparison with a modern open necrosectomy cohort[J]. J Am Coll Surg, 2020, 230(6):873-883. doi: 10.1016/j.jamcollsurg.2020.01.038 URL
[52]	Chang YT, Coombs G, Ling T, et al. Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013[J]. Int J Antimicrob Agents, 2017, 49(6):734-739. doi: 10.1016/j.ijantimicag.2017.01.030 URL
[53]	Zhang WF, Li ZT, Fang JJ, et al. Expression and clinical significance of rhubarb on serum amylase and TNF-alpha of rat model of acute pancreatitis[J]. J Biol Regul Homeost Agents, 2017, 31(3):753-760.